| Literature DB >> 28443072 |
Taru Singh1, Shukla Das1, V G Ramachandran2,3, Sayim Wani2,3, Dheeraj Shah4, Khan A Maroof5, Aditi Sharma6.
Abstract
Integrons by means of horizontal gene transfer carry multidrug resistance genes (MDR) among bacteria, including E. coli. The aim of this study was to determine the antibiotic resistance profiles and the genes associated with them, to gain insights in the distribution of phylogroups, prevalence, and characterization of class 1, 2 and 3 integrons among Enteropathogenic E. coli (EPEC) isolates, from children upto 5 years of age from Delhi and National Capital Region (NCR), India. A total of 120 E. coli isolates, including 80 from diarrheagenic E. coli (cases) and 40 from healthy isolates (controls) were recruited in this study. After isolation of E. coli, screening for EPEC was done by conventional multiplex PCR. Antibiotic suseptibility test was performed using disk diffusion method and further confirmed by minimum inhibitory concentration (MICs) by E-test. The presence and characterization of integrons and antimicrobial resistance genes were performed by PCR and DNA sequencing. Phylogeny determination was carried out by quadruplex PCR. EPEC strains were found in 64 of the 80 diarrheagenic cases, out of which 38 were MDR. In the 40 healthy controls, 23 were found to be EPEC strain, out of which only 2 were MDR. Amongst 80 diarrheagenic cases, class 1 integron were observed in 43 isolates, class 2 integron in 12 isolates and 9 isolates were found with co-existence of both. Similarly, in healthy controls; class 1 integron in 9 and class 2 integron in 7 isolates were observed with co-existence in 3 isolates. None of the isolates included class 3 integron. The dfr was the most commonly identified gene cassette within the integron-positive isolates. Phylogenetic studies showed considerable representation of phylogroup B2 in both diarrheagenic cases and healthy controls. This study reiterates the importance of class 1 integron predominantly for acquisition of antibiotic resistance genes among EPEC isolates. Furthermore, it also ascertains the possible association between multidrug resistance and presence of integrons. Approximately 91% of isolates were easily assigned to their respective phylogroups. Assessment of the relationship between antibiotic resistance and dominant phylogroups detected was also attempted. This study also highlights the increased burden of antimicrobial resistance in healthy controls.Entities:
Keywords: enteropathogenic Escherichia coli; gene cassettes; integrons; multidrug resistance; phylogenetic groups
Year: 2017 PMID: 28443072 PMCID: PMC5385330 DOI: 10.3389/fmicb.2017.00561
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Age and sex distribution of isolates in diarrheagenic cases and healthy controls.
| (0–1) | 20 | 11 | 31(38.75) / 35 (43.75) | 10 | 1 | 11(27.5) / 18 (45) | 0.03 |
| (1–3) | 9 | 7 | 16(20) / 20 (25) | 5 | 1 | 6(15) / 8 (20) | 0.77 |
| (3–5) | 9 | 8 | 17(21.25) / 25 (31.25) | 4 | 2 | 6(15) / 14 (35) | 0.12 |
| Total | 38 | 26 | 64(80) / 80 (100) | 19 | 4 | 23(57.5) / 40 (100) | 0.00 |
Gene frequencies are presented as absolute numbers with percentage in parentheses.
EPEC, Enteropathogenic E. coli.
significant p-value.
M, Male;
F, Female.
Figure 1Multiplex PCR for EPEC virulence genes showing typical EPEC and atypical EPEC on 1.5% agarose gel. Lane 1, molecular weight marker (100 bp, Fermentas); lane 2, eae (482 bp) for atypical EPEC; lane 3, bfpA (326 bp) + eae (482 bp) for typical EPEC and lane 4, no template control (negative) control. Non-pathogenic E. coli ATCC 11775 was used as a negative control.
Figure 2Multiplex PCR for integrase genes on 1.5% agarose gel. Multiplex PCR products of class 1 integrase (170 bp) and class 2 integrase genes (403 bp) lane 1–7: lane 8, molecular weight marker (100 bp, Fermentas); lanes 9, no template control (negative) control.
Distribution of integron among EPEC and non-EPEC isolates.
| Integron 1 | 43 (67.18) | 9 (39.13) | 0.018 | 3.14 (1.16–8.75) | 9 (56.25) | 6 (35.29) | 0.227 | 2.295 (0.475–12.03) | 52 (59.77) | 15 (45.45) | 0.158 | 1.774 (0.786–4.047) |
| Integron 2 | 12 (18.75) | 7 (30.43) | 0.245 | 0.699 (0.24–2.01) | 4 (25) | 3 (17.64) | 0.636 | 1.535 (0.265–9.725) | 19 (21.83) | 7 (21.21) | 0.940 | 1.037 (0.394–2.931) |
| Integron 1+ Integron 2 | 9 (14.06) | 3 (13.04) | 0.937 | 0.689 (0.15–3.01) | 3 (18.75) | 2 (11.76) | 0.618 | 1.702 (0.221–16.21) | 12 (13.79) | 5 (15.15) | 0.833 | 0.896 (0.293–3.059) |
| Total | 64 (100) | 19 (82.6) | 0.003 | N.A | 16 (100) | 11 (64.7) | 0.011 | N.A | 83 (95.4) | 27 (81.81) | 0.03 | 4.54 (1.159–19.48) |
significant P-value.
Gene frequencies are presented as absolute numbers with percentage in parentheses.
EPEC, Enteropathogenic E. coli.
Association between antimicrobial resistance and integrons.
| Norfloxacin | 26 (13) | 14 (12.7) | 0.07 |
| Cefotaxime | 67 (55.8) | 31 (28.1) | 0.000 |
| Imipenem | 18 (15) | 13 (11.8) | 0.48 |
| Meropenem | 3 (2.5) | 2 (1.8) | 0.75 |
| Ceftazidime | 12 (10) | 2 (1.8) | 0.009 |
| Azetronam | 11 (9.1) | 1 (0.9) | 0.004 |
| Nalidixic acid | 14(11.6) | 3 (2.7) | 0.009 |
| Amoxicillin | 3 (2.5) | 1 (0.9) | 0.41 |
| Gentamicin | 31 (25.8) | 17 (15.4) | 0.05 |
| Ciprofloxacin | 12(10) | 7 (6.3) | 0.33 |
| Ampicillin | 30 (25) | 26 (23.6) | 0.53 |
| Amikacin | 23 (19.1) | 14 (12.7) | 0.19 |
| Polymixin B | 1 (0.8) | 0 (0) | >0.99 |
| Cefotaxime+ clavulanic acid | 1 (0.8) | 1 (0.9) | 0.95 |
| Ceftriaxone | 2(1.6) | 0 (0) | 0.271 |
| Piperacillin+tazobactam | 21 (17.5) | 12 (10.9) | 0.16 |
significant p-value.
Frequencies are presented as absolute numbers with percentage in parentheses.
Relation between presence of integron and MDR.
| Integron positive ( | 54(98.18) | 56 (86.15) | <0.0 |
| Integron negative ( | 1(1.81) | 9(13.84) | |
| Total | 55 | 65 | |
significant p-value.
Frequencies are presented as absolute numbers with percentage in parentheses.
MDR, multi drug resistance
Distribition of antibiotic resistance genes.
| 23 (35.9) | 8 (34.7) | 11 (68.7) | 8 (47) | 31 (35.6) | 19 (57.5) | ||
| 22 (34.3) | 5 (21.7) | 6 (37.5) | 6 (35.2) | 27 (31) | 12 (36.3) | 0.58 | |
| 12 (18.7) | 5 (21.7) | 3 (18.7) | 3 (17.6) | 17 (19.5) | 6 (18.1) | 0.88 | |
| 12 (18.7) | 2 (8.6) | 1 (6.2) | 5 (29.4) | 14 (16) | 6 (18.1) | 0.77 | |
| 5 (7.8) | 6 (26) | 1 (6.2) | 0 (0) | 11 (12.6) | 1 (3) | 0.12 | |
| 5 (7.8) | 5 (21.7) | 2 (12.5) | 1 (5.8) | 10 (11.5) | 3 (9) | 0.74 | |
| 9 (14) | 6 (26) | 3 (18.7) | 1 (5.8) | 15 (17.2) | 4 (12.1) | 0.51 | |
| 6 (9.3) | 4 (17.4) | 3 (18.7) | 2 (11.7) | 10 (11.5) | 5 (15.1) | 0.59 | |
| 3 (4.6) | 1 (4.3) | 1 (6.2) | 2 (11.7) | 4 (4.5) | 2 (6) | 0.73 | |
| 4 (6.2) | 0 (0) | 3 (18.7) | 3 (17.6) | 4 (4.5) | 6 (18.1) | 0.03 | |
| 30 (46.8) | 13 (56.5) | 8 (50) | 6 (35.2) | 43 (49.4) | 14 (42.4) | 0.49 | |
| 17 (26.5) | 2 (8.6) | 2 (12.5) | 3 (17.6) | 19 (21.8) | 5 (15.1) | 0.43 | |
| 15 (23.4) | 1 (4.3) | 6 (37.5) | 1 (5.8) | 16 (18.3) | 7 (21.2) | 0.72 | |
DC, diarrheagenic cases; HC, healthy controls; EPEC, enteropathogenic E. coli.
Statistically significant.
Figure 3Phylogrouping of EPEC isolates: Quadruplex PCR profiles of new Clermont phylotyping method. arpA (400 bp), chuA (288 bp), yjaA (211 bp), and TspE4.C2 (152 bp) Lane 1, unknown (− − − +); lane 2, unknown (+ + + +); lane 3, group F (− + − −); lane 4, group B2 (− + + −); lane 5, group F (− + − −); lane 6, M: molecular weight marker (100 bp, Fermentas). lane 7, group B1 (+ − − +); lane 8, group B1 (+ − − +); lane 9, group F (− + − −); lane 10, group B2 (− + + −). PCR products were loaded on 1.5% agarose gel after electrophoresis; gels were photographed under UV light.
Distribution of phylogenetic groups in EPEC and non-EPEC isolates.
| 11 (17.1) | 5 (21.7) | 16(18.3) | 1(6.2) | 2(11.7) | 3(9.0) | |
| 12 (18.7) | 4 (17.3) | 16 (18.3) | 3(18.7) | 7(41.1) | 10(30.3) | |
| 25(39.0) | 8(34.7) | 33 (37.9) | 7(43.7) | 4(23.5) | 11(33.3) | |
| 2 (3.1) | 1 (4.3) | 3 (3.4) | 0(0) | 0(0) | 0(0) | |
| 4 (6.2) | 2 (8.6) | 6 (6.8) | 0(0) | 0(0) | 0(0) | |
| 1 (1.5) | 1 (4.3) | 2 (2.2) | 1(6.2) | 1(5.8) | 2(11.7) | |
| 3 (4.6) | 0 | 3 (3.4) | 2(12.5) | 2(11.7) | 4(23.5) | |
| 0 | 0 | 0 | 0(0) | 0(0) | 0(0) | |
| 6(9.3) | 2 (8.6) | 8 (9.1) | 2(12.5) | 1(5.8) | 3(9.0) | |
Gene frequencies are presented as absolute numbers with percentage in parentheses.
DC, diarrheagenic cases;
HC, healthy controls;
T, total.
Frequency of antimicrobial resistance among the prevalent phylogenetic groups in EPEC and non-EPEC isolates from diarrheagenic cases and healthy controls.
| Norfloxacin | 20(22.9) | 12(13.7) | 0.619 | 6(18.1) | 6(18.1) | >0.99 |
| Cefotaxime | 62(71.2) | 21(24.1) | 0.002 | 5(15.1) | 5(15.1) | >0.99 |
| Imipenem | 14 (16.1) | 3(3.4) | 0.515 | 4 (12.1) | 0 | N.A |
| Meropenem | 3(3.4) | 0 | 0.207 | 0 | 0 | N.A |
| Ceftazidime | 12(13.7) | 2(2.2) | 0.090 | 0 | 0 | N.A |
| Azetronam | 11(12.6) | 2(2.2) | 0.127 | 0 | 0 | N.A |
| Nalidixic acid | 14(16) | 2(2.2) | 0.044 | 0 | 0 | N.A |
| Amoxicillin | 3(3.4) | 0 | 0.207 | 0 | 0 | N.A |
| Gentamicin | 29 (33.3) | 7(8.0) | 0.014 | 2(6) | 2(6) | >0.99 |
| Ciprofloxacin | 12(13.7) | 10(11.5) | 0.657 | 0 | 0 | N.A |
| Ampicillin | 20 (23) | 0 | 0.001 | 10 (30.3) | 0 | 0.001 |
| Amikacin | 23(26.4) | 3(3.4) | 0.004 | 0 | 0 | N.A |
| Polymixin B | 1(1.1) | 0 | 0.648 | 0 | 0 | N.A |
| Cefotaxime+ clavulanic acid | 1(1.1) | 0 | 0.648 | 0 | 0 | N.A |
| Ceftriaxone | 2(2.2) | 0 | 0.419 | 0 | 0 | N.A |
| Piperacillin+tazobactam | 20 (22.9) | 3 (3.4) | 0.010 | 1(3) | 1(3) | >0.99 |
significant p-value.
Frequencies are presented as absolute numbers with percentage in parentheses.